CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BIIB

Omaveloxolone capsules, 2.5 mg

Phase 2
Biogen Inc. (BIIB)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

1

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in MItochondrial Myopathies

View Full Landscape
Drug Information

Target Indication

MItochondrial Myopathies

Clinical Trial

NCT02255422

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals
EMA2/9/2024

Skyclarys

The treatment of Friedreich’s ataxia in adults and adolescents aged 16 years and older.

Orphan
View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.